News

The funding will take Umecrine to study readout

“The study is continuing according to plan, and our assessment is that the round should cover the remaining...

Publicerad: 8 June, 2026

KDventures participated in Redeye's event Next Gen Healthcare on May 26. The presentation was held by...

Publicerad: 22 May, 2026

Analyst firm Redeye has initiated coverage of KDventures. The first report is now published, providing...

Publicerad: 13 May, 2026

Positive data from the GOAL-HF1 Phase 1b/2a study were presented on May 11, 2026 at the ESC Heart Failure...

Publicerad: 13 May, 2026

Comment

The year began with us changing the company's name to KDventures – a name change that marks a new start...

Publicerad: 30 April, 2026